The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD

Sun, Qingan; Li, Xiaojun; Perez, Lisa M.; Shi, Wanliang; Zhang, Ying; Sacchettini, James C.

doi:10.1038/s41467-019-14238-3

Title: The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD

Journal Article · 17 January 2020 · Nature Communications

DOI: https://doi.org/10.1038/s41467-019-14238-3 · OSTI ID:1603168

^[1]; Li, Xiaojun ^[1];

^[1]; Shi, Wanliang ^[2]; Zhang, Ying ^[2]; Sacchettini, James C. ^[1]

Texas A & M Univ., College Station, TX (United States)
Johns Hopkins Univ., Baltimore, MD (United States)

Pyrazinamide has been a mainstay in the multidrug regimens used to treat tuberculosis. It is active against the persistent, non-replicating mycobacteria responsible for the protracted therapy required to cure tuberculosis. Pyrazinamide is a pro-drug that is converted into pyrazinoic acid (POA) by pyrazinamidase, however, the exact target of the drug has been difficult to determine. Here we show the enzyme PanD binds POA in its active site in a manner consistent with competitive inhibition. The active site is not directly accessible to the inhibitor, suggesting the protein must undergo a conformational change to bind the inhibitor. This is consistent with the slow binding kinetics we determined for POA. Drug-resistant mutations cluster near loops that lay on top of the active site. These resistant mutants show reduced affinity and residence time of POA consistent with a model where resistance occurs by destabilizing the closed conformation of the active site.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States)

Sponsoring Organization:: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); USDOE

OSTI ID:: 1603168

Journal Information:: Nature Communications, Journal Name: Nature Communications Journal Issue: 1 Vol. 11; ISSN 2041-1723

Publisher:: Nature Publishing GroupCopyright Statement

Country of Publication:: United States

Language:: ENGLISH

References (44)

Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD Chopra, Sidharth; Pai, Harish; Ranganathan, Anand Protein Expression and Purification, Vol. 25, Issue 3 https://doi.org/10.1016/s1046-5928(02)00039-6	journal	August 2002
Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis Zimhony, Oren; Cox, Jeffery S.; Welch, John T. Nature Medicine, Vol. 6, Issue 9 https://doi.org/10.1038/79558	journal	September 2000
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis Zhang, Shuo; Chen, Jiazhen; Shi, Wanliang Emerging Microbes & Infections, Vol. 2, Issue 1 https://doi.org/10.1038/emi.2013.38	journal	January 2013
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis Shi, Wanliang; Chen, Jiazhen; Feng, Jie Emerging Microbes & Infections, Vol. 3, Issue 1 https://doi.org/10.1038/emi.2014.61	journal	January 2014
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus Scorpio, Angelo; Zhang, Ying Nature Medicine, Vol. 2, Issue 6 https://doi.org/10.1038/nm0696-662	journal	June 1996
The intrinsic structure of poly(A) RNA determines the specificity of Pan2 and Caf1 deadenylases Tang, Terence T. L.; Stowell, James A. W.; Hill, Chris H. Nature Structural & Molecular Biology, Vol. 26, Issue 6 https://doi.org/10.1038/s41594-019-0227-9	journal	May 2019
Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA Dillon, Nicholas A.; Peterson, Nicholas D.; Feaga, Heather A. Scientific Reports, Vol. 7, Issue 1 https://doi.org/10.1038/s41598-017-06415-5	journal	July 2017
Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid Zhang, Y. Journal of Antimicrobial Chemotherapy, Vol. 52, Issue 5 https://doi.org/10.1093/jac/dkg446	journal	September 2003
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/s0021889807021206	journal	July 2007
Polder maps: improving OMIT maps by excluding bulk solvent Liebschner, Dorothee; Afonine, Pavel V.; Moriarty, Nigel W. Acta Crystallographica Section D Structural Biology, Vol. 73, Issue 2, p. 148-157 https://doi.org/10.1107/s2059798316018210	journal	February 2017
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis Shi, W.; Zhang, X.; Jiang, X. Science, Vol. 333, Issue 6049 https://doi.org/10.1126/science.1208813	journal	August 2011
Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis Peterson, Nicholas D.; Rosen, Brandon C.; Dillon, Nicholas A. Antimicrobial Agents and Chemotherapy, Vol. 59, Issue 12 https://doi.org/10.1128/aac.00967-15	journal	September 2015
Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Salfinger, M.; Heifets, L. B. Antimicrobial Agents and Chemotherapy, Vol. 32, Issue 7 https://doi.org/10.1128/aac.32.7.1002	journal	July 1988
Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I Boshoff, H. I.; Mizrahi, V.; Barry, C. E. Journal of Bacteriology, Vol. 184, Issue 8 https://doi.org/10.1128/jb.184.8.2167-2172.2002	journal	April 2002
Validation of Drug-Like Inhibitors against Mycobacterium Tuberculosis L-Aspartate α-Decarboxylase Using Nuclear Magnetic Resonance (1H NMR) Sharma, Reetu; Florea, Mara; Nau, Werner M. PLoS ONE, Vol. 7, Issue 9 https://doi.org/10.1371/journal.pone.0045947	journal	September 2012
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization Concepcion, Joy; Witte, Krista; Wartchow, Charles Combinatorial Chemistry & High Throughput Screening, Vol. 12, Issue 8 https://doi.org/10.2174/138620709789104915	journal	September 2009
Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD Chopra, Sidharth; Pai, Harish; Ranganathan, Anand Protein Expression and Purification, Vol. 25, Issue 3 https://doi.org/10.1016/S1046-5928(02)00039-6	journal	August 2002
Crystal Structure of the Schiff Base Intermediate Prior to Decarboxylation in the Catalytic Cycle of Aspartate α-Decarboxylase Lee, Byung Il; Suh, Se Won Journal of Molecular Biology, Vol. 340, Issue 1 https://doi.org/10.1016/j.jmb.2004.04.049	journal	June 2004
In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1 Gopal, Pooja; Tasneen, Rokeya; Yee, Michelle ACS Infectious Diseases, Vol. 3, Issue 7 https://doi.org/10.1021/acsinfecdis.7b00017	journal	March 2017
Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD Gopal, Pooja; Nartey, Wilson; Ragunathan, Priya ACS Infectious Diseases, Vol. 3, Issue 11 https://doi.org/10.1021/acsinfecdis.7b00079	journal	October 2017
LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery Laskowski, Roman A.; Swindells, Mark B. Journal of Chemical Information and Modeling, Vol. 51, Issue 10 https://doi.org/10.1021/ci200227u	journal	October 2011
Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P. Journal of Medicinal Chemistry, Vol. 49, Issue 21 https://doi.org/10.1021/jm051256o	journal	October 2006
Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis Zimhony, Oren; Cox, Jeffery S.; Welch, John T. Nature Medicine, Vol. 6, Issue 9 https://doi.org/10.1038/79558	journal	September 2000
Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis Zhang, Shuo; Chen, Jiazhen; Shi, Wanliang Emerging Microbes & Infections, Vol. 2, Issue 1 https://doi.org/10.1038/emi.2013.38	journal	January 2013
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis Shi, Wanliang; Chen, Jiazhen; Feng, Jie Emerging Microbes & Infections, Vol. 3, Issue 1 https://doi.org/10.1038/emi.2014.61	journal	January 2014
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus Scorpio, Angelo; Zhang, Ying Nature Medicine, Vol. 2, Issue 6 https://doi.org/10.1038/nm0696-662	journal	June 1996
A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis Sambandamurthy, Vasan K.; Wang, Xiaojuan; Chen, Bing Nature Medicine, Vol. 8, Issue 10 https://doi.org/10.1038/nm765	journal	September 2002
TrkA undergoes a tetramer-to-dimer conversion to open TrkH which enables changes in membrane potential Zhang, Hanzhi; Pan, Yaping; Hu, Liya Nature Communications, Vol. 11, Issue 1 https://doi.org/10.1038/s41467-019-14240-9	journal	January 2020
The oligomeric structures of plant cryptochromes Shao, Kai; Zhang, Xue; Li, Xu Nature Structural & Molecular Biology, Vol. 27, Issue 5 https://doi.org/10.1038/s41594-020-0420-x	journal	May 2020
Anti-tubercular Activity of Pyrazinamide is Independent of trans-Translation and RpsA Dillon, Nicholas A.; Peterson, Nicholas D.; Feaga, Heather A. Scientific Reports, Vol. 7, Issue 1 https://doi.org/10.1038/s41598-017-06415-5	journal	July 2017
Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid Zhang, Y. Journal of Antimicrobial Chemotherapy, Vol. 52, Issue 5 https://doi.org/10.1093/jac/dkg446	journal	September 2003
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide Sun, Zhonghe; Zhang, Ying; Permar, Sallie Journal of Medical Microbiology, Vol. 51, Issue 1 https://doi.org/10.1099/0022-1317-51-1-42	journal	January 2002
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 8 https://doi.org/10.1107/S0907444906019949	journal	July 2006
Polder maps: improving OMIT maps by excluding bulk solvent Liebschner, Dorothee; Afonine, Pavel V.; Moriarty, Nigel W. Acta Crystallographica Section D Structural Biology, Vol. 73, Issue 2, p. 148-157 https://doi.org/10.1107/S2059798316018210	journal	February 2017
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis Shi, W.; Zhang, X.; Jiang, X. Science, Vol. 333, Issue 6049 https://doi.org/10.1126/science.1208813	journal	August 2011
Identification of Novel Mutations in LprG ( rv1411c ), rv0521 , rv3630 , rv0010c , ppsC , and cyp128 Associated with Pyrazinoic Acid/Pyrazinamide Resistance in Mycobacterium tuberculosis Shi, Wanliang; Chen, Jiazhen; Zhang, Shuo Antimicrobial Agents and Chemotherapy, Vol. 62, Issue 7 https://doi.org/10.1128/AAC.00430-18	journal	April 2018
Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis Peterson, Nicholas D.; Rosen, Brandon C.; Dillon, Nicholas A. Antimicrobial Agents and Chemotherapy, Vol. 59, Issue 12 https://doi.org/10.1128/AAC.00967-15	journal	September 2015
Introducing RpsA Point Mutations Δ438A and D123A into the Chromosome of Mycobacterium tuberculosis Confirms Their Role in Causing Resistance to Pyrazinamide Shi, Wanliang; Cui, Peng; Niu, Hongxia Antimicrobial Agents and Chemotherapy, Vol. 63, Issue 6 https://doi.org/10.1128/AAC.02681-18	journal	March 2019
Pantothenate and Pantetheine Antagonize the Antitubercular Activity of Pyrazinamide Dillon, Nicholas A.; Peterson, Nicholas D.; Rosen, Brandon C. Antimicrobial Agents and Chemotherapy, Vol. 58, Issue 12 https://doi.org/10.1128/AAC.04028-14	journal	September 2014
Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Salfinger, M.; Heifets, L. B. Antimicrobial Agents and Chemotherapy, Vol. 32, Issue 7 https://doi.org/10.1128/AAC.32.7.1002	journal	July 1988
Effects of Pyrazinamide on Fatty Acid Synthesis by Whole Mycobacterial Cells and Purified Fatty Acid Synthase I Boshoff, H. I.; Mizrahi, V.; Barry, C. E. Journal of Bacteriology, Vol. 184, Issue 8 https://doi.org/10.1128/JB.184.8.2167-2172.2002	journal	April 2002
Validation of Drug-Like Inhibitors against Mycobacterium Tuberculosis L-Aspartate α-Decarboxylase Using Nuclear Magnetic Resonance (1H NMR) Sharma, Reetu; Florea, Mara; Nau, Werner M. PLoS ONE, Vol. 7, Issue 9 https://doi.org/10.1371/journal.pone.0045947	journal	September 2012
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization Concepcion, Joy; Witte, Krista; Wartchow, Charles Combinatorial Chemistry & High Throughput Screening, Vol. 12, Issue 8 https://doi.org/10.2174/138620709789104915	journal	September 2009

Similar Records

Inhibitors of Mycobacterium tuberculosis EgtD target both substrate binding sites to limit hercynine production

Journal Article · 2021 · Scientific Reports · OSTI ID:1832565

Sudasinghe, Thanuja D.; Banco, Michael T.; Ronning, Donald R.

Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA

Journal Article · 2018 · Life Science Alliance · OSTI ID:1545852

Xia, Yi; Zhou, Yasheen; Carter, David S.; +21 more

Evaluation of a radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis

Journal Article · 1986 · Antimicrob. Agents Chemother.; (United States) · OSTI ID:6702704

Tarrand, J J; Spicer, A D; Groeschel, D H

Related Subjects

59 BASIC BIOLOGICAL SCIENCES

Title: The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD

Citation Formats

References (44)

Similar Records

Related Subjects